Igm Biosciences, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
IGM Biosciences files an amendment to its annual report to provide additional details on its board of directors, executive compensation, and corporate governance practices.
IGM Biosciences pivots to autoimmunity, reports significant losses, and outlines strategic alternatives in its latest 10-K filing.
IGM Biosciences updates its employee stock purchase plan and formalizes its outside director compensation policy, detailing cash retainers, equity grants, and clawback provisions.